September/October 2023
NPAC’s ED presented at the European Pain Federation’s 2023 Congress on a global initiative to establish core research domains for pain. She spoke about involving people with lived experience, whose votes were weighted equally to those of researchers and clinicians.
NPAC was selected to present at the DEA’s listening Session on Telemedicine Prescribing. NPAC’s President provided its testimony.
NPAC successfully advocated with The Board of Pharmacy Specialties (BPS) to create a new specialty in pain management pharmacy.
NPAC’s ED, and Science and Policy Advisors, Baker and Mallampalli, participated in the fall meeting of the Interagency Pain Research Coordinating Committee.
NPAC’s ED joined the governing board of NIH PURPOSE, a new initiative to build the pain workforce and support collaboration among researchers.
NPAC’s ED spoke in Washington, D.C., to the 2023 Mayday Fellows on strategies for advocacy and policy change